| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
946 |
776 |
$74K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,161 |
345 |
$39K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,102 |
355 |
$35K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,721 |
558 |
$32K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
236 |
236 |
$27K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
596 |
530 |
$21K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,487 |
1,473 |
$17K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
591 |
570 |
$16K |
| 80061 |
Lipid panel |
1,502 |
1,494 |
$16K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
572 |
553 |
$16K |
| 80053 |
Comprehensive metabolic panel |
1,967 |
1,879 |
$14K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
738 |
222 |
$14K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
673 |
592 |
$13K |
| J3490 |
Unclassified drugs |
13 |
12 |
$12K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
620 |
617 |
$12K |
| 97010 |
|
937 |
274 |
$10K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,827 |
1,745 |
$9K |
| 97163 |
|
58 |
58 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
991 |
984 |
$6K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
263 |
263 |
$6K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
186 |
186 |
$5K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
68 |
63 |
$4K |
| 97164 |
|
26 |
25 |
$3K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
134 |
134 |
$3K |
| 86803 |
|
203 |
203 |
$2K |
| 84439 |
|
401 |
399 |
$2K |
| 99072 |
|
943 |
894 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
25 |
25 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
243 |
235 |
$1K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
26 |
26 |
$1K |
| 76830 |
Ultrasound, transvaginal |
25 |
25 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
57 |
57 |
$1K |
| 81001 |
|
520 |
510 |
$1K |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
68 |
57 |
$1K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
12 |
12 |
$915.20 |
| 76642 |
|
12 |
12 |
$799.90 |
| 82607 |
|
85 |
85 |
$714.09 |
| 87340 |
|
95 |
95 |
$693.22 |
| 97014 |
|
46 |
12 |
$666.08 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
129 |
39 |
$647.15 |
| A7038 |
Filter, disposable, used with positive airway pressure device |
88 |
88 |
$537.91 |
| 86592 |
|
148 |
148 |
$465.41 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
23 |
13 |
$449.28 |
| 71046 |
Radiologic examination, chest; 2 views |
25 |
24 |
$447.27 |
| 99401 |
|
46 |
40 |
$427.02 |
| 84153 |
|
30 |
30 |
$407.91 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
296 |
195 |
$381.25 |
| 82274 |
|
34 |
34 |
$363.49 |
| 99215 |
Prolong outpt/office vis |
131 |
105 |
$343.20 |
| 82043 |
|
81 |
79 |
$330.30 |
| 96156 |
|
16 |
16 |
$325.00 |
| 82746 |
|
33 |
33 |
$259.63 |
| 90686 |
|
13 |
13 |
$258.39 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
28 |
26 |
$258.06 |
| 87088 |
|
33 |
31 |
$199.57 |
| 96160 |
|
70 |
70 |
$191.25 |
| 83540 |
|
44 |
43 |
$183.44 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
13 |
12 |
$177.76 |
| 85652 |
|
84 |
83 |
$171.73 |
| 81003 |
|
107 |
107 |
$143.20 |
| 82728 |
|
14 |
13 |
$130.80 |
| 82570 |
|
26 |
25 |
$85.28 |
| 84436 |
|
14 |
14 |
$84.42 |
| 83550 |
|
18 |
17 |
$82.68 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
16 |
12 |
$65.21 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14 |
14 |
$62.44 |
| 85027 |
|
17 |
17 |
$46.53 |
| 92015 |
Determination of refractive state |
12 |
12 |
$32.04 |
| 81002 |
|
14 |
13 |
$30.10 |
| 83735 |
|
16 |
14 |
$14.98 |
| 83690 |
|
13 |
13 |
$13.20 |
| 36415 |
Collection of venous blood by venipuncture |
1,998 |
1,922 |
$0.00 |
| G9637 |
Final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique) |
51 |
51 |
$0.00 |
| 1111F |
|
263 |
243 |
$0.00 |
| 3008F |
|
363 |
344 |
$0.00 |
| 1036F |
|
164 |
161 |
$0.00 |
| 7025F |
|
220 |
220 |
$0.00 |
| 3341F |
|
12 |
12 |
$0.00 |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
232 |
217 |
$0.00 |
| 1126F |
|
89 |
86 |
$0.00 |
| 3074F |
|
174 |
165 |
$0.00 |
| 98961 |
|
127 |
114 |
$0.00 |
| 99205 |
Prolong outpt/office vis |
28 |
28 |
$0.00 |
| 1220F |
|
28 |
28 |
$0.00 |
| 1125F |
|
13 |
13 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
30 |
29 |
$0.00 |
| G9557 |
Final reports for ct, cta, mri or mra studies of the chest or neck without an incidentally found thyroid nodule < 1.0 cm noted or no nodule found |
13 |
13 |
$0.00 |
| 3078F |
|
158 |
150 |
$0.00 |
| 99051 |
|
97 |
94 |
$0.00 |
| G9551 |
Final reports for imaging studies without an incidentally found lesion noted |
59 |
58 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
13 |
13 |
$0.00 |